AHIP AHM-510 Exam - Topic 4 Question 28 Discussion
The Good & Well Pharmacy, a Medicaid provider of outpatient drugs, is subject to the prospective drug utilization review (DUR) mandates of the Omnibus Budget Reconciliation Act of 1990 (OBRA '90). One component of prospective DUR is screening. In this context, when Good & Well is involved in the process of screening, the pharmacy is
B) Reviewing patient profiles for the purpose of identifying potential problems
A) Updating a formulary to represent the current clinical judgment of providers and experts in the diagnosis and treatment of disease
C) Consulting directly with prescribers and patients in the planning of drug therapy
D) Denying coverage for the off-label use of approved drugs
Leonora
8 months agoVeronika
8 months agoArlene
8 months agoJade
8 months agoEdwin
8 months agoEvangelina
9 months agoCherri
9 months agoMarleen
9 months ago